📰 Statistics Review News
Statistics Review News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Statistics Review. Real-time updates on events, politics, business and more.
October 23, 2023
Early data show an overall survival trend favoring the combination of amivantamab and lazertinib compared to osimertinib; consistent results seen in...
October 6, 2023
The addition of PARP inhibitors for the treatment of patients with BRCA-mutated advanced ovarian cancer has provided clinicians with a stronger set of treatment options. Looking at how the BRCA mutation responds to these inhibitors is then vital to deciding the patient’s treatment path.
May 25, 2023
Liquid biopsies could usher in a paradigm shift in cancer detection and grow exponentially.
May 23, 2023
Liquid biopsies could usher in a paradigm shift in cancer detection and grow exponentially.
March 3, 2023
/PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced that the U.S. Food and Drug Administration (FDA) approved an expanded indication for...
August 31, 2022
Myriad Genetics' EndoPredict test accurately identified premenopausal women with ER+, HER2- breast cancer who could safely avoid adjuvant chemotherapy SALT LAKE CITY, Aug. 31, 2022 1 that shows the
May 24, 2022
New data show proportions of patients treated with TREMFYA who achieved clinical-biomarker response ranged from 47.5-66.7 percent across dose grou...
May 6, 2022
Statistics for 2021 show the year was the busiest on record
March 9, 2022
/PRNewswire/ -- The National Comprehensive Cancer Network® (NCCN®)—an alliance of leading cancer centers—today announced the publication of new NCCN Clinical...